Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk

Lingyang Hua, Leihao Ren, Qian Wu, Jiaojiao Deng, Jiawei Chen, Haixia Cheng, Daijun Wang, Hong Chen, Qing Xie, Hiroaki Wakimoto, Ye Gong

2022Journal of Neuro-Oncology11 citationsDOI

Topics & Concepts

MedicineTumor progressionCohortMeningiomaRetrospective cohort studyProgression-free survivalOncologyBiomarkerInternal medicinePathologyOverall survivalCancerBiologyBiochemistryMeningioma and schwannoma managementBrain Metastases and TreatmentNeurofibromatosis and Schwannoma Cases

Loss of H3K27me3 expression enriches in recurrent grade 1&amp;2 meningiomas and maintains as a biomarker stratifying progression risk

Topics & Concepts

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk